BioSeeker Group is a renowned provider of the cancer drug intelligence solution 1stOncology. With locations in Stockholm, Sweden and Boston, USA, the company has been serving as a global aggregator of commercial drug development information in oncology since 1999.
1stOncology™, the award-winning business development service offered by BioSeeker Group, is a leading oncology intelligence analytic solution. It aims to empower clients by providing insightful analysis and opportunities across various domains including new technologies, target scouting, indication selection/expansion, combinatorial drug settings, drug repositioning, and first in class analysis.
Although the current headquarters and latest investment details of BioSeeker Group are not specified, the company continues to make strides in the realm of Marketing with its pioneering offerings in the field of oncology intelligence. The company's resolute focus on providing cutting-edge solutions in cancer drug intelligence cements its position as an impactful player in the industry.